Hackensack University Medical Ctr

Hackensack, New Jersey 07601

1 studies enrolling now · 7 studies all time

What they study most

Chronic Myelogenous Leukemia - Chronic Phase, Cutaneous T-cell Lymphoma (CTCL),, Extensive Stage Small Cell Lung Cancer, High-Risk Percutaneous Coronary Intervention, Leukemia, Myelomonocytic, Chronic, Multiple Myeloma, Myelodysplastic Syndromes, Relapsing Multiple Sclerosis (RMS)

Studies at this site

• A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab — Running, not enrolling
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab — Running, not enrolling
• Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol — Enrolling by invitation
• Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) — Stopped early
• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma — Completed